Your browser doesn't support javascript.
loading
Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy.
Emran, Abdullah Al; Chatterjee, Aniruddha; Rodger, Euan J; Tiffen, Jessamy C; Gallagher, Stuart J; Eccles, Michael R; Hersey, Peter.
Afiliação
  • Emran AA; Melanoma Immunology and Oncology Group, The Centenary Institute, University of Sydney, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW 2050, Australia; These authors contributed equally.
  • Chatterjee A; Department of Pathology, Dunedin School of Medicine, University of Otago, 270 Great King Street, Dunedin 9054, New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery, Level, 3A Symonds Street, Auckland, New Zealand; These authors contributed equally.
  • Rodger EJ; Department of Pathology, Dunedin School of Medicine, University of Otago, 270 Great King Street, Dunedin 9054, New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery, Level, 3A Symonds Street, Auckland, New Zealand.
  • Tiffen JC; Melanoma Immunology and Oncology Group, The Centenary Institute, University of Sydney, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW 2050, Australia.
  • Gallagher SJ; Melanoma Immunology and Oncology Group, The Centenary Institute, University of Sydney, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW 2050, Australia.
  • Eccles MR; Department of Pathology, Dunedin School of Medicine, University of Otago, 270 Great King Street, Dunedin 9054, New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery, Level, 3A Symonds Street, Auckland, New Zealand; Senior author.
  • Hersey P; Melanoma Immunology and Oncology Group, The Centenary Institute, University of Sydney, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW 2050, Australia; Senior author. Electronic address: p.hersey@centenary.org.au.
Trends Immunol ; 40(4): 328-344, 2019 04.
Article em En | MEDLINE | ID: mdl-30853334

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Metilação de DNA / Proteína Potenciadora do Homólogo 2 de Zeste / Imunoterapia / Melanoma Limite: Humans Idioma: En Revista: Trends Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Metilação de DNA / Proteína Potenciadora do Homólogo 2 de Zeste / Imunoterapia / Melanoma Limite: Humans Idioma: En Revista: Trends Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de publicação: Reino Unido